Ticker Details
Soleno Therapeutics, Inc. Common Stock Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases.
IPO Date:	November 10, 2014
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$2.76B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.47 | 3.61%
Avg Daily Range (30 D):	$0.04 | 0.07%
Avg Daily Range (90 D):	$0.76 | 1.98%

Institutional Daily Volume
Avg Daily Volume:	.55M
Avg Daily Volume (30 D):	1.66M
Avg Daily Volume (90 D):	2.47M

Trade Size
Avg Trade Size (Sh.):	132
Avg Trade Size (Sh.) (30 D):	140
Avg Trade Size (Sh.) (90 D):	115

Institutional Trades
Total Institutional Trades:	3,105
Avg Institutional Trade:	$3.06M
Avg Institutional Trade (30 D):	$4.56M
Avg Institutional Trade (90 D):	$3.69M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	4

Market Closing Trades
Avg Closing Trade:	$6.14M
Avg Closing Trade (30 D):	$12.96M
Avg Closing Trade (90 D):	$9.52M
Avg Closing Volume:	114.82K

News

May 5, 2026 @ 1:00 PM Portnoy Law Firm Announces Class Action on Behalf ... Source: Portnoy Law Firm

May 4, 2026 @ 9:47 PM SOLENO THERAPEUTICS CLASS ACTION DEADLINE TOMORROW... Source: Bragar Eagel & Squire, P.C.

May 2, 2026 @ 1:45 AM SOLENO THERAPEUTICS DEADLINE: ROSEN, LEADING INVES... Source: Rosen Law Firm

Apr 30, 2026 @ 4:00 PM Bronstein, Gewirtz & Grossman LLC Urges Soleno The... Source: Bronstein, Gewirtz & Grossman Llc

Apr 30, 2026 @ 4:00 PM Bronstein, Gewirtz & Grossman LLC Urges Atara Biot... Source: Bronstein, Gewirtz & Grossman Llc

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$1.85	$.6	$.85
Diluted EPS	$1.81	$.59	$.84
Revenue	$285.01M	$94.6M	$91.73M
Gross Profit	$281.11M	$93.41M	$90.87M
Net Income / Loss	$96.04M	$31.38M	$43.36M
Operating Income / Loss	$86.44M	$31.28M	$39.58M
Cost of Revenue	$3.9M	$1.2M	$.86M
Net Cash Flow	$51.7M	$62.92M	$-176.56M
PE Ratio

Splits
Aug 26, 2022	1:15
Oct 06, 2017	1:5